BP394

Minocycline hydrochloride

British Pharmacopoeia (BP) Reference Standard

• Empirický vzorec (Hillův zápis): C₂₃H₂₇N₃O₇ · HCl
• Číslo CAS: 13614-98-7
• Molekulová hmotnost: 493.94
• UNSPSC Code: 41116107
• NACRES: NA.24
• MDL number: MFCD00083669
• eCl@ss: 25140904

Vlastnosti

• grade: pharmaceutical primary standard
• API family: minocycline
• form: powder
• quality: British Pharmacopoeia (BP) Reference Standard
• shelf life: limited shelf life, expiry date on the label
• manufacturer/tradename: BP
• application(s): pharmaceutical; pharmaceutical small molecule
• format: neat
• storage temp.: 2-8°C
• SMILES string: Cl.CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)N(C)C
• InChI: 1S/C23H27N3O7.ClH/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28;/h5-6,9,11,17,27,29-30,33H,7-8H2,1-4H3,(H2,24,32);1H/t9-,11-,17-,23-;/m0./s1
• InChI key: GLMUAFMGXXHGLU-VQAITOIOSA-N

Popis

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Minocycline hydrochloride BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Minocycline Tablets

Minocycline Capsules

Minocycline Prolonged-Release Capsules

Tigecycline for Infusion

Packaging

Unit quantity: 125 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Other Notes

Sales restrictions may apply.

Bezpečnostní informace

• Skladovací třída: 11 - Combustible Solids
• Co se děje?: WGK 3
• Bod vzplanutí (°F): Not applicable
• Bod vzplanutí (°C): Not applicable